Lazard Asset Management’s Cartesian Therapeutics RNAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-371
| Closed | -$7K | – | 2334 |
|
|
2023
Q4 | $7K | Sell |
371
-21
| -5% | -$396 | ﹤0.01% | 2109 |
|
|
2023
Q3 | $12K | Buy |
392
+19
| +5% | +$582 | ﹤0.01% | 2137 |
|
|
2023
Q2 | $12K | Buy |
373
+8
| +2% | +$257 | ﹤0.01% | 2173 |
|
|
2023
Q1 | $14K | Sell |
365
-1,534
| -81% | -$58.8K | ﹤0.01% | 2103 |
|
|
2022
Q4 | $63K | Buy |
1,899
+287
| +18% | +$9.52K | ﹤0.01% | 1703 |
|
|
2022
Q3 | $79K | Buy |
+1,612
| New | +$79K | ﹤0.01% | 1584 |
|
|
2022
Q1 | – | Sell |
-619
| Closed | -$60K | – | 2506 |
|
|
2021
Q4 | $60K | Buy |
619
+197
| +47% | +$19.1K | ﹤0.01% | 1656 |
|
|
2021
Q3 | $52K | Buy |
+422
| New | +$52K | ﹤0.01% | 1669 |
|